NewEdge Advisors’s Immunogen Inc IMGN Stock Holding History

NewEdge Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,488	Closed	-$7.38K	–	4278
2022 Q4	$7.38K	Buy	+1,488	New	+$8.07K	﹤0.01%	2461

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewEdge Advisors's IMGN Position: Q1 2023 in Review

NewEdge Advisors sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 1,488 shares — an estimated $7.38K sold.

NewEdge Advisors first reported a position in IMGN in Q4 2022 and held it in 1 quarter. The position peaked at $7.38K in Q4 2022. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

NewEdge Advisors reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 1,488 Immunogen Inc shares in Q1 2023, an estimated $7.38K.
NewEdge Advisors first reported a position in Immunogen Inc in Q4 2022 and held it in 1 quarter.
NewEdge Advisors's Immunogen Inc position peaked at $7.38K in Q4 2022.
190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.